Clinical trial
Long Term Natural History of PTS and Other Adverse Outcomes After Venous Thromboembolism in the Optimev Study (SPOT)
NCT03054727 is registered in ClinicalTrials.gov with Association des Médecins Vasculaires Hospitaliers as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Natural History of PTS and Other Adverse Outcomes After Venous Thromboembolism in the Optimev Study (SPOT)
- Lead sponsor
- Association des Médecins Vasculaires Hospitaliers
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 11, 2017
- Completion date
- December 31, 2022
- Enrollment
- 2,475 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, post thrombotic syndrome, venous thromboembolism